Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy

American Journal of Surgery

Volumn 184, Issue 4, 2002, Pages 299-301

  Baslaim, Muna M ^a   Al Malik, Osama A ^b   Al Sobhi, Saif S ^b   Ibrahim, Ezzeldin ^b   Ezzat, Adnan ^b   Ajarim, Dahish ^b   Tulbah, Asma ^b   Chaudhary, Mohammad A ^b   Sorbris, Ralph A ^b  

^a KING FAHAD GENERAL HOSPITAL   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Axillary lymph node retrieval; Locally advanced breast cancer; Neoadjuvant chemotherapy

Indexed keywords

ANTHRACYCLINE; PACLITAXEL;

ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ANTIBIOTICS, ANTINEOPLASTIC; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY, MODIFIED RADICAL; NEOADJUVANT THERAPY; NEOPLASM STAGING; PACLITAXEL; RETROSPECTIVE STUDIES;

EID: 0036806365     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(02)00959-5     Document Type: Article

References (9)

1. Ezzat A., Ezzeldin I., Ajarim D., et al. High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin. Breast Ca Res Treat. 62:2000;237-244.
2. Kuerer H., Newman L., Buzdar A., et al. Residual axillary lymph nodes following neoadjuvant chemotherapy predict disease free survival in patients with locally advanced breast cancer. Am J Surg. 176:1998;502-550.
3. Kuerer M., Newman L., Fornage B., et al. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Am Surg Oncol. 5:1998;673-680.
4. Kuerer H.M., Newman L.A., Smith T.L., et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol. 17:1999;460-469.
5. Kuerer H.M., Singletary E. Integration of neoadjuvant chemotherapy and surgery in the treatment of patients with breast carcinoma. Breast Dis. 12:2001;69-81.
6. Honkoop A.H., Pendo H.M., De Jong J.S., et al. Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol. 107:1997;211-218.
7. Sneige N., Kemp B., Pusztai L., et al. Chemotherapy-induced histologic changes in mastectomy specimens and their potential significance. Breast. 10:2001;492-500.
8. Ezzat A., Raja M., Rostom A., et al. An overview of breast cancer. Ann Saudi Med. 17:1997;10-15.
9. Petrek J.A., Blackwood M.M. Axillary dissection current practice and technique. Wells S.A., Current problems in surgery. Vol 32:1995;259-323 Mosby, St. Louis.